Literature DB >> 15149297

Lipid and lipoprotein levels in depressive disorders with melancholic feature or atypical feature and dysthymia.

Tiao-Lai Huang1, Jung-Fu Chen.   

Abstract

The purpose of the present study was to explore the relationship between serum lipid and lipoprotein levels and clinical subtypes in patients with depressive disorders. A total of 207 patients who were admitted for general health screening were assessed by using the semistructured clinical interview for Diagnostic and Statistical Manual of Mental Disorders (4th edn; DSM-IV) criteria for the possibility of having depressive disorders. Blood and physical examinations were done to rule out systemic diseases. A total of 142 patients without systemic diseases was recruited for further analysis, including dysthymia (n = 35), major depressive disorder with melancholic feature (n = 22), major depressive disorder with atypical feature (n = 46) and normal controls (n = 39). Analysis of covariance after age adjustment reveals significant differences in patients with melancholic feature and patients with atypical feature in serum concentrations of triglyceride (TG) and very-low-density-lipoprotein cholesterol (VLDL) in men, and high-density-lipoprotein cholesterol (HDL) in women. This suggests that the TG, VLDL and HDL levels might be used as biological markers to differentiate between major depressive patients with melancholic feature or atypical feature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149297     DOI: 10.1111/j.1440-1819.2004.01235.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  8 in total

Review 1.  Depression and serum low-density lipoprotein: A systematic review and meta-analysis.

Authors:  Jane E Persons; Jess G Fiedorowicz
Journal:  J Affect Disord       Date:  2016-07-19       Impact factor: 4.839

2.  Relationship between depression and apolipoproteins A and B: a case-control study.

Authors:  Masoumeh Sadeghi; Hamidreza Roohafza; Hamid Afshar; Fereshteh Rajabi; Mohamadarash Ramzani; Hasan Shemirani; Nizal Sarafzadeghan
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Waist-to-hip ratio, dyslipidemia, glycemic levels, blood pressure and depressive symptoms among diabetic and non-diabetic Chinese women: a cross-sectional study.

Authors:  Yu Zheng; Qihong Sun; Kang Chen; Wenhua Yan; Changyu Pan; Juming Lu; Jingtao Dou; Zhaohui Lu; Ba Jianming; Baoan Wang; Yiming Mu
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

4.  Total serum cholesterol, atherogenic indices and their longitudinal association with depressive symptoms among US adults.

Authors:  M A Beydoun; H A Beydoun; G A Dore; M T Fanelli-Kuczmarski; M K Evans; A B Zonderman
Journal:  Transl Psychiatry       Date:  2015-03-03       Impact factor: 6.222

5.  Is low total cholesterol levels associated with suicide attempt in depressive patients?

Authors:  A Messaoud; R Mensi; A Mrad; A Mhalla; I Azizi; B Amemou; I Trabelsi; M H Grissa; N Haj Salem; A Chadly; W Douki; M F Najjar; L Gaha
Journal:  Ann Gen Psychiatry       Date:  2017-04-17       Impact factor: 3.455

6.  Examining the Influence of Early Life Stress on Serum Lipid Profiles and Cognitive Functioning in Depressed Patients.

Authors:  Ágnes Péterfalvi; Nándor Németh; Róbert Herczeg; Tamás Tényi; Attila Miseta; Boldizsár Czéh; Maria Simon
Journal:  Front Psychol       Date:  2019-08-06

7.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16

8.  Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population.

Authors:  Marcela Segoviano-Mendoza; Manuel Cárdenas-de la Cruz; José Salas-Pacheco; Fernando Vázquez-Alaniz; Osmel La Llave-León; Francisco Castellanos-Juárez; Jazmín Méndez-Hernández; Marcelo Barraza-Salas; Ernesto Miranda-Morales; Oscar Arias-Carrión; Edna Méndez-Hernández
Journal:  BMC Psychiatry       Date:  2018-01-15       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.